Antwerp, Belgium – April 14, 2025 – Idevax, a pioneering medical device company specializing in innovative skin drug delivery solutions, today announced that its flagship… Read More »Idevax Announces CE Marking for VAX-ID Intradermal Drug Delivery Device
simAbs has received their FAGG GMP (Good Manufacturing Practice) license! This is a major milestone that reflects their dedication to quality, safety, and excellence in… Read More »simAbs is officially GMP-certified
P95 BV, a full-service Contact Research Organization (CRO) specializing in vaccine development and infectious diseases, and LatinaBA, a regional CRO with over 15 years conducting clinical… Read More »P95 and LatinaBA enter a strategic partnership to propel vaccine research in Latin America
Our member, Naobios, a CDMO (Contract Development and Manufacturing Organization) providing bioprocess development and GMP production of clinical batches of virus-based products, and Sumagen Canada… Read More »Naobios and Sumagen successfully optimize HIV vaccine candidate for industrial production
BioProcess International had the great opportunity to speak to Eric Halioua, CEO of our member, PDC*line Pharma, on the company’s journey from its inception to its… Read More »Start Up Stories Eric Halioua: PDC*line Pharma
Our member, Idevax, a pioneering company specializing in innovative skin drug delivery technology, announced the successful closing of a €3 million Series A funding round. The investment was led… Read More »Idevax Secures €3M in Series A Funding to Revolutionize Skin Drug Delivery
